Clinical Trials Browser

Phase 1 × Leukemia, Lymphocytic, Chronic, B-Cell × NVP-BKM120 × Clear all

NCT02614508 2019-09-03

Buparlisib and Ofatumumab or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell